Merit Medical Systems Inc
$ 82.43
1.00%
24 Feb - close price
- Market Cap 4,838,677,000 USD
- Current Price $ 82.43
- High / Low $ 82.81 / 80.86
- Stock P/E 41.85
- Book Value 25.80
- EPS 1.95
- Next Earning Report 2026-02-24
- Dividend Per Share N/A
- Dividend Yield 0 %
- Next Dividend Date -
- ROA 0.04 %
- ROE 0.08 %
- 52 Week High 107.27
- 52 Week Low 77.62
About
Merit Medical Systems, Inc. manufactures and markets disposable medical devices for interventional, diagnostic, and therapeutic procedures in cardiology, radiology, oncology, intensive care, and endoscopy. The company is headquartered in South Jordan, Utah.
Analyst Target Price
$103.64
Quarterly Earnings
| Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 | Sep 2024 | Jun 2024 | Mar 2024 | Dec 2023 | Sep 2023 | Jun 2023 | Mar 2023 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Reported Date | 2026-02-24 | 2025-10-30 | 2025-07-30 | 2025-04-28 | 2025-02-26 | 2024-10-30 | 2024-08-01 | 2024-04-30 | 2024-02-28 | 2023-10-26 | 2023-07-25 | 2023-04-26 |
| Reported EPS | 0 | 0.92 | 1.01 | 0.86 | 0.93 | 0.86 | 0.92 | 0.77 | 0.81 | 0.75 | 0.81 | 0.64 |
| Estimated EPS | 0.9498 | 0.83 | 0.8475 | 0.7493 | 0.83 | 0.8 | 0.87 | 0.71 | 0.77 | 0.65 | 0.75 | 0.55 |
| Surprise | -0.9498 | 0.09 | 0.1625 | 0.1107 | 0.1 | 0.06 | 0.05 | 0.06 | 0.04 | 0.1 | 0.06 | 0.09 |
| Surprise Percentage | -100% | 10.8434% | 19.174% | 14.7738% | 12.0482% | 7.5% | 5.7471% | 8.4507% | 5.1948% | 15.3846% | 8% | 16.3636% |
Next Quarterly Earnings
| Dec 2025 | |
|---|---|
| Reported Date | 2026-02-24 |
| Fiscal Date Ending | 2025-12-31 |
| Estimated EPS | 0.85 |
| Currency | USD |
Next Dividend Records
| Dividend per share (year): | - |
| Dividend Yield | - |
| Next Dividend Date | - |
| Ex-Dividend Date | - |
Recent News: MMSI
2026-02-24 21:55:59
Merit Medical Systems (NASDAQ:MMSI) announced better-than-expected revenue for Q4 CY2025, with sales up 10.9% year-on-year to $393.9 million, surpassing analyst estimates. Both the full-year revenue guidance and adjusted EBITDA also beat expectations, although non-GAAP profit for the quarter slightly missed consensus estimates. The company showed strong operating margin improvement and impressive long-term EPS growth, despite a minor miss on quarterly adjusted EPS.
2026-02-24 21:52:58
Merit Medical Systems Inc. has released its 2025 10-K report, showcasing robust financial performance with net sales of $1,515.9 million and a net income of $128.5 million. The report highlights strong growth in cardiovascular segments, strategic acquisitions to expand its product portfolio, and significant investments in a new distribution facility. Despite its successes, the company faces challenges including supply chain disruptions, geopolitical instability, healthcare industry pressures, technological competition, and foreign currency exchange rate fluctuations.
2026-02-24 20:52:59
Merit Medical Systems, Inc. announced strong financial results for Q4 and full year 2025, with reported revenue up 11% and 12% respectively. The company also provided fiscal year 2026 guidance, projecting total revenue between $1.610 billion and $1.630 billion, and non-GAAP EPS of $4.01 to $4.15, reflecting continued growth and improved profitability. These results underscore the company's successful execution of its operating and financial strategies.
2026-02-24 20:52:59
Merit Medical Systems, Inc. (MMSI) announced its Q4 adjusted EPS was $1.04 per share, surpassing FactSet's estimate of $0.95. This financial update indicates a stronger-than-expected performance for the quarter, signaling positive results for the company. The report also highlights rising non-GAAP EPS and sales for Q4, alongside a fiscal 2026 outlook.
2026-02-23 04:04:30
Merit Medical Systems (MMSI) is set to report its Q4 earnings on Tuesday after market close. The market anticipates a 9.8% year-on-year revenue growth, aligning with its past performance and analyst reconfirmations. The company previously beat revenue expectations with a 13% year-on-year increase in the last quarter, and its stock price has remained stable despite an overall underperforming healthcare equipment and supplies segment.
2026-02-18 15:28:00
Piper Sandler has cut its price target on Merit Medical Systems (NASDAQ: MMSI) to $106 from $113, while maintaining an Overweight rating. The firm anticipates a potential upside in gross margin percentage and expects conservative guidance from management to lead to higher Street estimates. Despite trading at a high P/E, InvestingPro's Fair Value assessment suggests the stock is undervalued, and recent developments include new board leadership and analyst coverage from BTIG.
